Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19

Published:2020-07 Issue:7 Volume:10 Page:1205-1215
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Liu Xiaoyan,Li Zhe,Liu Shuai,Sun Jing,Chen Zhanghua,Jiang Min,Zhang Qingling,Wei Yinghua,Wang Xin^ORCID,Huang Yi-You,Shi Yinyi,Xu Yanhui,Xian Huifang,Bai Fan^ORCID,Ou Changxing,Xiong Bei,Lew Andrew M.,Cui Jun,Fang Rongli,Huang Hui,Zhao Jincun,Hong Xuechuan^ORCID,Zhang Yuxia^ORCID,Zhou Fuling,Luo Hai-Bin

Funder

National Key R&D Program of China

National Natural Science Foundation of China

National Health & Medical Research of Australia

Science Foundation of Guangzhou City

Guangdong Province Higher Vocational Colleges and Schools Pearl River Scholar Funded Scheme

Guangdong Provincial Key Laboratory of Construction Foundation

Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program

Zhejiang University special scientific research fund for COVID-19 prevention and control

Taikang Insurance Group Co., Ltd.

Beijing Taikang Yicai Foundation

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference52 articles.

1. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study;Chen;Lancet,2020

2. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China;Huang;Lancet,2020

3. First case of 2019 novel coronavirus in the United States;Holshue;N Engl J Med,2020

4. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan;Chan;Emerg Microb Infect,2020

5. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China;Wu;Cell Host Microbe,2020

Cited by 195 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fragment-based Drug Discovery Strategy and its Application to the Design of SARS-CoV-2 Main Protease Inhibitor;Current Medicinal Chemistry;2024-11

2. Platelet dysfunction caused by differentially expressed genes as key pathogenic mechanisms in COVID-19;Minerva Cardiology and Angiology;2024-09

3. Adenosine A2AR in viral immune evasion and therapy: unveiling new avenues for treating COVID-19 and AIDS;Molecular Biology Reports;2024-08-08

4. von Willebrand factor antigen, von Willebrand factor propeptide and ADAMTS13 activity in TIA or ischaemic stroke patients changing antiplatelet therapy;Journal of the Neurological Sciences;2024-08

5. The Anticancer Effects and Therapeutic Potential of Kaempferol in Triple-Negative Breast Cancer;Nutrients;2024-07-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3